SEK299.80
3.29% yesterday
Stockholm, Sep 27, 05:29 pm CET
ISIN
SE0009858152
Symbol
BONEX
Sector

Bonesupport Holding AB Stock price

SEK299.80
+4.80 1.63% 1M
+73.80 32.65% 6M
+111.60 59.30% YTD
+178.30 146.75% 1Y
+258.75 630.33% 3Y
+269.20 879.74% 5Y
+267.80 836.88% 10Y
Stockholm, Closing price Fri, Sep 27 2024
-10.20 3.29%
ISIN
SE0009858152
Symbol
BONEX
Sector

Key metrics

Market capitalization SEK19.70b
Enterprise Value SEK19.60b
P/E (TTM) P/E ratio 67.63
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 26.67
P/S ratio (TTM) P/S ratio 26.80
P/B ratio (TTM) P/B ratio 31.30
Revenue growth (TTM) Revenue growth 64.11%
Revenue (TTM) Revenue SEK735.16m
EBIT (operating result TTM) EBIT SEK74.50m
Free Cash Flow (TTM) Free Cash Flow SEK-21.88m
Cash position SEK114.58m
EPS (TTM) EPS SEK4.43
P/E forward 167.17
P/S forward 22.10
EV/Sales forward 21.99
Show more

Is Bonesupport Holding AB a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

Bonesupport Holding AB Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Bonesupport Holding AB forecast:

3x Buy
100%

Analyst Opinions

3 Analysts have issued a Bonesupport Holding AB forecast:

Buy
100%

Financial data from Bonesupport Holding AB

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
735 735
64% 64%
100%
- Direct Costs 57 57
42% 42%
8%
678 678
66% 66%
92%
- Selling and Administrative Expenses 539 539
40% 40%
73%
- Research and Development Expense 65 65
18% 18%
9%
84 84
475% 475%
11%
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 74 74
341% 341%
10%
Net Profit 289 289
1,063% 1,063%
39%

In millions SEK.

Don't miss a Thing! We will send you all news about Bonesupport Holding AB directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

BONESUPPORT HOLDING AB engages in the development and commercialization of injectable bioceramic bone graft substitutes to treat bone voids. It markets its products through its propriety CERAMENT technology platform. The firm's products focuses on the treatment of trauma, revision arthro-plasty, chronic osteomyelitis, and foot infections and ankle surgery. It operates through the North America, and Europe and Rest of the World geographical segments. The company was founded by Lars Åke Alvar Lidgren and Fredrik Lindberg in 1999 and is headquartered in Lund, Sweden.

Head office Sweden
CEO Emil Billbäck
Employees 118
Founded 2010
Website www.bonesupport.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today